Stand Up To Cancer Canada (SU2C Canada), together with Canadian Breast Cancer Foundation (CBCF) with support from CIBC, Cancer Stem Cell Consortium (CSCC), Genome Canada, Canadian Institutes of Health Research (CIHR), and the Ontario Institute for Cancer Research (OICR), is pleased to announce that up to $22.6 million CAD is available to fund two separate cancer research Dream Teams to accelerate the pace of groundbreaking research to bring new treatments from the laboratory to patients faste
Dr. Stephen Scherer, Senior Scientist and Director of the Centre for Applied Genomics at The Hospital for Sick Children (SickKids), has been selected as a 2014 “Nobel-class” Citation Laureate in the category of physiology or medicine, according to an announcement Sept.25 by Thomson Reuters Intellectual Property & Science (Thomson Reuters IP & Science).
$30 Million CAD Pledged by Canadian Health Charities, Government-Funded Organizations, Corporations and the Public
Inaugural SU2C Canada Dream Teams to Begin Research in Summer 2015
Genome Canada is delighted to welcome Mr. Paul-Émile Cloutier as Vice President Advocacy and External Relations. Mr. Cloutier is responsible for managing a portfolio which includes government and stakeholder relations, communications, events and sponsorships and Genomics in Society activities.
Cancer Stem Cell Consortium Welcomes Stand Up to Cancer Canada
Initiative aimed at ending cancer's reign as leading cause of death
Ottawa, Ontario, July 9, 2014 — Members of the Cancer Stem Cell Consortium (CSCC) today welcomed the announcement of a new Canadian initiative to fight cancer and the unveiling of plans for a major televised fundraising event to take place on September 5.